- Home
- CABO vs CNTA Comparison
CABO vs CNTA Comparison
Compare CABO & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CABO
- CNTA
- Stock Information
- Founded
- CABO 1980
- CNTA 2020
- Country
- CABO United States
- CNTA United Kingdom
- Employees
- CABO N/A
- CNTA N/A
- Industry
- CABO Cable & Other Pay Television Services
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- CABO Telecommunications
- CNTA Health Care
- Exchange
- CABO Nasdaq
- CNTA Nasdaq
- Market Cap
- CABO 2.0B
- CNTA 2.3B
- IPO Year
- CABO N/A
- CNTA 2021
- Fundamental
- Price
- CABO $366.05
- CNTA $17.50
- Analyst Decision
- CABO Hold
- CNTA Strong Buy
- Analyst Count
- CABO 5
- CNTA 7
- Target Price
- CABO $554.40
- CNTA $23.71
- AVG Volume (30 Days)
- CABO 72.9K
- CNTA 581.0K
- Earning Date
- CABO 02-20-2025
- CNTA 11-12-2024
- Dividend Yield
- CABO 3.27%
- CNTA N/A
- EPS Growth
- CABO 847.26
- CNTA N/A
- EPS
- CABO 38.05
- CNTA N/A
- Revenue
- CABO $1,604,144,000.00
- CNTA $6,853,000.00
- Revenue This Year
- CABO N/A
- CNTA N/A
- Revenue Next Year
- CABO N/A
- CNTA N/A
- P/E Ratio
- CABO $9.62
- CNTA N/A
- Revenue Growth
- CABO N/A
- CNTA N/A
- 52 Week Low
- CABO $311.28
- CNTA $6.65
- 52 Week High
- CABO $574.53
- CNTA $18.97
- Technical
- Relative Strength Index (RSI)
- CABO 41.82
- CNTA 53.43
- Support Level
- CABO $358.73
- CNTA $15.45
- Resistance Level
- CABO $372.49
- CNTA $18.00
- Average True Range (ATR)
- CABO 10.91
- CNTA 1.14
- MACD
- CABO -1.31
- CNTA -0.05
- Stochastic Oscillator
- CABO 44.24
- CNTA 76.78
About CABO Cable One Inc.
Cable One Inc is a telecommunications company. It derives revenue from the provision of broadband, voice, and video services to residential and business customers. From a product perspective, the majority of revenue is sourced from data and video services. This revenue is subscription-based and billed monthly. The company also offers Sparklight TV, an internet protocol-based (IPTV) video service that allows customers with Sparklight TV app to stream video channels from the cloud. The company also derives advertising revenue from selling airtime on its video channels. Voice services are offered over Internet protocols. The company owns a telecommunications infrastructure.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.